Amarin Corporation plc (AMRN) compared with its closest peers (VNDA, IDYA, PBYI, ANAB, AKBA). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Vanda Pharmaceuticals, IDEAYA Biosciences, Puma Biotechnology, AnaptysBio, Akebia Therapeutics, Rhythm Pharmaceuticals, Keros Therapeutics, Maravai LifeSciences, Arcus Biosciences and Stoke Therapeutics share Amarin's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Vanda Pharmaceuticals Inc. (VNDA) | $332.55M | -2.4 |
| IDEAYA Biosciences, Inc. (IDYA) | $3.87B | -27.0 |
| Puma Biotechnology, Inc. (PBYI) | $500.71M | 18.7 |
| AnaptysBio, Inc. (ANAB) | $1.63B | -105.4 |
| Akebia Therapeutics, Inc. (AKBA) | $264.21M | -80.3 |
| Rhythm Pharmaceuticals, Inc. (RYTM) | $7.25B | -34.4 |
| Keros Therapeutics, Inc. (KROS) | $223.25M | 8.8 |
| Maravai LifeSciences Holdings, Inc. (MRVI) | $1.09B | -3.6 |
| Arcus Biosciences, Inc. (RCUS) | $3.75B | -7.2 |
| Stoke Therapeutics, Inc. (STOK) | $1.90B | -264.3 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
AMRN overview · AMRN earnings · AMRN financials · AMRN KPIs · AMRN documents · AMRN ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.